Mycoplasma Testing Market by End-user, Product and Geography - Forecast and Analysis 2023-2027

Published: Jul 2023 Pages: 170 SKU: IRTNTR43492

Mycoplasma Testing Market Analysis Report 2023-2027:

The mycoplasma testing market size is estimated to grow by USD 645.51 million at a CAGR of 12.25% between 2022 and 2027. 

There is increasing adoption of real-time mycoplasma testing across the hospital sectors. One of the main advantages of real-time mycoplasma testing is that it quickly offers the presence of mycoplasma contamination in biological products, unlike traditional testing which requires days or months to deliver the mycoplasma test results. Additionally, there is an increasing focus by several market players on the development of real-time mycoplasma testing products. For instance, MycoSEQ Mycoplasma Detection System is developed by Thermo Fisher Scientific, which offers test results in hours and is integrated with real-time PCR assays and systems along with software with optimized PrepSEQ sample preparation reagent. Furthermore, there is a growing popularity for real-time mycoplasma testing products in cell lines, cell banks, pharmaceutical and biotechnology companies, CROs, research institutes, and harvest media which is expected to positively impact the market growth.

Technavio has segmented the market into  End-user, Product, and Geography.

  • The end-user segment is classified into pharmaceutical and biotechnology companies, cell banks, academic research institutes, CROs, and others.
  • The product segment is classified into consumables and systems
  • The geography segment includes key regions such as North America, Europe, Asia, and Rest of the World (ROW)

It also includes an in-depth analysis of drivers, trends, and challenges. Our report examines historic data from 2017 to 2021, besides analyzing the current market scenario.

What will be the Size of the Mycoplasma Testing Market During the Forecast Period?

To learn more about this report, Request Free Sample

Mycoplasma Testing Market Segmentation by  End-user, Product, and Geography Analysis

End-user Analysis

Pharmaceutical and biotechnology companies

The pharmaceutical and biotechnology companies segment is estimated to witness significant growth during the forecast period. One of the major causes of batch failure in biopharmaceutical production is microbial contamination, such as mycoplasma contamination. These contaminations can result in significant loss of time and material, leading to loss of revenue to the biopharmaceutical companies. Hence, mycoplasma testing is vital for these companies at various stages in the manufacturing process.

Get a glance at the market contribution of various segments View a PDF Sample

The pharmaceutical and biotechnology companies segment was the largest segment and was valued at USD 200.92 million in 2017. Mycoplasma testing products are widely used to identify the presence of microbes such as mycoplasma detected in the early stage of the production process which can significantly reduce the loss incurred by biotechnology and pharmaceutical companies. Additionally, there is increasing support from the government which is resulting in growing R&D activities in drug development by biopharmaceutical companies. Hence, such factors are expected to drive the growth of this segment which in turn will drive the global mycoplasma testing market growth during the forecast period.

Product Analysis

Consumables

The consumables segment is widely used for identifying mycoplasma contamination such as kits and reagents including PCR assays, nucleic acid detection kits, staining materials, elimination kits and reagents, standards, and controls. The kits and reagents are frequently used in mycoplasma testing and need regular purchases by pharmaceutical companies and biomedical research organizations. Several prominent market players such as InvivoGen manufactures test kit such as essays for the visual detection of mycoplasma in the cell culture. Hence, such factors are expected to fuel the growth of this segment which in turn will drive the global mycoplasma testing market growth during the forecast period.

Systems

The mycoplasma testing systems are mainly used to identify mycoplasma contamination, especially in cell cultures, as it is a widespread and frequent problem in a wide variety of cell cultures. The presence or absence of mycoplasma contaminants is identified by these systems. There is an increasing demand for these systems in pharmaceutical and biotechnology companies, cell banks, academic research institutes, and CROs due to their ability to quickly identify mycoplasma within a few hours. Furthermore, several prominent players are manufacturing real-time mycoplasma detection systems due to their high adoption. Hence,  such factors are expected to fuel the growth of this segment which in turn will drive the global mycoplasma testing market growth during the forecast period.

Regional Analysis

For more insights about the market share of various regions View PDF Sample now!

North America is estimated to contribute 40% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that will shape the market during the forecast period. One of the main factors which are significantly contributing to the growth of the global mycoplasma testing market in North America is due to the rising number of life science researchers and the presence of life science research firms and laboratories such as the Charles River Laboratories and Gibraltar Laboratories. Some of the key end-users which use mycoplasma testing for controlling mycoplasma contamination are biotechnology, biological, and pharmaceutical companies.

Therefore, several laboratories perform mycoplasma testing which helps the companies to avoid mycoplasma contamination. Factors such as increasing focus on drug and vaccine discovery and development, recent advances in biotechnology and pharmaceutical research, and the presence of several prominent market players in the region offering a wide range of mycoplasma testing products are significantly fuelling the market growth in the region during the forecast period.

COVID Recovery Analysis

In 2020, during the COVID-19 pandemic, the growth of global mycoplasma testing market witnessed significant growth as the number of co-infection cases increased significantly in North America, resulting in increased demand for mycoplasma testing However, in 2021, the initiation of large-scale vaccination drives?has lifted the lockdown and travel restrictions, decrease in demand for mycoplasma testing due to decrease in COVID cases. But the continuous development in biotechnology in the region is expected to drive the market during the forecast period.

Buy Now Full Report and Discover More

Key Mycoplasma Testing Market Players 

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 20 market companies, including:

Agilent Technologies Inc: The company offers mycoplasma testing products such as MycoSensor qPCR assay kits.

  • ATCC
  • Akron Biotechnology LLC
  • Becton Dickinson and Co.
  • Bio-Techne Corp.
  • Bionique Testing Laboratories Inc.
  • Charles River Laboratories International Inc.
  • DiaSorin SpA
  • Dilarus GmbH
  • F. Hoffmann La Roche Ltd.
  • GeneCopoeia Inc.
  • InvivoGen Corp.
  • Lonza Group Ltd.
  • Merck KGaA
  • Norgen Biotek Corp.
  • PromoCell GmbH
  • Sartorius AG
  • ScienCell Research Laboratories Inc.
  • SGS SA
  • Thermo Fisher Scientific Inc.

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Mycoplasma Testing Market: Key Drivers, Trends, Challenges, and Customer Landscape

There are multiple factors influencing market growth. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. 

Key Mycoplasma Testing Market Drivers

One of the key factors driving the global mycoplasma testing market growth is the growing geriatric population. One of the rapidly growing segments in the global population is the geriatric segment. According to the estimates by The World Bank Group and the NIH, the proportion of the geriatric population in the global population is expected to grow from 8.48% in 2016 to approximately 17% by 2050. The main reason is the advancement in several healthcare technologies which resulted in the availability of more efficient treatment options leading to increased life expectancy.

Additionally, the increase in median age due to growing life expectancy resulted in the growth in the elderly adult population. Factors such as the shift in causes of death from fatal acute infections to chronic conditions such as arthritis, diabetes, high cholesterol, and hypertension, especially due to changing lifestyle is leading to longevity. Additionally, several advancements in medicine have resulted in declining cases of disability. Hence, factors are expected to drive market growth during the forecast period.

Significant Mycoplasma Testing Market Trends

A key factor shaping the global mycoplasma testing market growth is the increasing initiatives for rapid diagnostics of infectious diseases. There is a significant increase in government funding to increase access to diagnostics via several technological innovations. Additionally, there is a rise in focus by several governments in developed and developing countries on enhancing access to mycoplasma testing products.

Furthermore, several market players in the global mycoplasma testing market are developing high-quality diagnostic technologies for chronic and infectious diseases but these are not accessible as well as affordable in some developing economies. As a result, the governments in these countries are undertaking many initiatives to improve access to diagnostics.  Additionally, with the help of international organizations such as Unitaid, several developing countries such as Brazil, South Africa, India, Zambia, and China are receiving access to in vitro diagnostic devices at preferential prices. Hence, such factors are expected to drive the global mycoplasma testing market growth during the forecast period.

Major Mycoplasma Testing Market Challenges

The high cost of mycoplasma testing products is one of the key challenges hindering market growth. The high cost associated with mycoplasma testing is due to the high price of products such as mycoplasma testing systems, assays, and frequently used consumables such as kits and reagents. The cost highly relies on the level of features provided by these products.

For instance, integrated systems such as the BD FACSMicroCount system provide a versatile and comprehensive solution for the rapid enumeration of microorganisms such as product screening, sterility testing, mycoplasma testing, and probiotic count. Hence, such integrated systems equipped with advanced features are expensive when compared to traditional mycoplasma testing systems. Hence, such factors are expected to hinder the global mycoplasma testing market growth during the forecast period.

Buy Now Full Report and Discover More

Key Mycoplasma Testing Market Customer Landscape

The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

Global Mycoplasma Testing Market Customer Landscape

Segment Overview

The mycoplasma testing market report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2017 to 2027. 

  • End-user Outlook (USD Million, 2017 - 2027)
    • Pharmaceutical and biotechnology companies
    • Cell banks
    • Academic research institutes
    • CROs
    • Others
  • Product Outlook (USD Million, 2017 - 2027)
    • Consumables
    • Systems
  • Geography Outlook (USD Million, 2017 - 2027)
    • North America
      • The U.S.
      • Canada
    • Europe
      • The U.K.
      • Germany
      • France
      • Rest of Europe
    • Asia
      • China
      • India
    • ROW
      • Brazil
      • Argentina
      • Australia

Mycoplasma Testing Market Scope

Report Coverage

Details

Page number

170

Base year

2022

Historic period

2017-2021

Forecast period

2023-2027

Growth momentum & CAGR

Accelerate at a CAGR of 12.25%

Market growth 2023-2027

USD 645.51 million

Market structure

Fragmented

YoY growth 2022-2023(%)

10.36

Regional analysis

North America, Europe, Asia, and Rest of the World (ROW)

Performing market contribution

North America at 40%

Key countries

US, Canada, UK, Germany, and China

Competitive landscape

 Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks

Key companies profiled

Agilent Technologies Inc., ATCC, Akron Biotechnology LLC, Becton Dickinson and Co., Bio-Techne Corp., Bionique Testing Laboratories Inc., Charles River Laboratories International Inc., DiaSorin SpA, Dilarus GmbH, F. Hoffmann La Roche Ltd., GeneCopoeia Inc., InvivoGen Corp., Lonza Group Ltd., Merck KGaA, Norgen Biotek Corp., PromoCell GmbH, Sartorius AG, ScienCell Research Laboratories Inc., SGS SA, and Thermo Fisher Scientific Inc.

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period.

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

View Sample PDF at your Fingertips

What are the Key Data Covered in this Mycoplasma Testing Market Research Report?

  • CAGR of the market during the forecast period
  • Detailed information on factors that will drive the growth of the global mycoplasma testing market between 2023 and 2027
  • Precise estimation of the mycoplasma testing market size and its contribution to the market in focus on the parent market
  • Detailed analysis of customer landscape covering driver of price sensitivity, Adoption of the lifecycle, and key purchase criteria 
  • Companies landscape comparing criticality of inputs and factors of differentiation
  • Exclusive Matrix on companies' position and classification
  • Accurate predictions about upcoming trends and changes in consumer behavior
  • Growth of the market across North America, Europe, Asia, and the Rest of the World (ROW)
  • A thorough analysis of the market’s competitive landscape and detailed information about companies
  • Comprehensive analysis of factors that will challenge the growth of mycoplasma testing market companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by End-user
    • Exhibit 06: Executive Summary – Chart on Market Segmentation by Product
    • Exhibit 07: Executive Summary – Chart on Incremental Growth
    • Exhibit 08: Executive Summary – Data Table on Incremental Growth
    • Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 10: Parent market
    • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 13: Market segments
  • 3.3 Market size 2022
    • 3.4 Market outlook: Forecast for 2022-2027
      • Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
      • Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
      • Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
      • Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

    4 Historic Market Size

    • 4.1 Global mycoplasma testing market 2017 - 2021
      • Exhibit 18: Historic Market Size – Data Table on global mycoplasma testing market 2017 - 2021 ($ million)
    • 4.2 End-user Segment Analysis 2017 - 2021
      • Exhibit 19: Historic Market Size – End-user Segment 2017 - 2021 ($ million)
    • 4.3 Product Segment Analysis 2017 - 2021
      • Exhibit 20: Historic Market Size – Product Segment 2017 - 2021 ($ million)
    • 4.4 Geography Segment Analysis 2017 - 2021
      • Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ million)
    • 4.5 Country Segment Analysis 2017 - 2021
      • Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ million)

    5 Five Forces Analysis

    • 5.1 Five forces summary
      • Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
    • 5.2 Bargaining power of buyers
      • Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
    • 5.3 Bargaining power of suppliers
      • Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
    • 5.4 Threat of new entrants
      • Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
    • 5.5 Threat of substitutes
      • Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
    • 5.6 Threat of rivalry
      • Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
    • 5.7 Market condition
      • Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

    6 Market Segmentation by End-user

    • 6.1 Market segments
      • Exhibit 30: Chart on End-user - Market share 2022-2027 (%)
      • Exhibit 31: Data Table on End-user - Market share 2022-2027 (%)
    • 6.2 Comparison by End-user
      • Exhibit 32: Chart on Comparison by End-user
      • Exhibit 33: Data Table on Comparison by End-user
    • 6.3 Pharmaceutical and biotechnology companies - Market size and forecast 2022-2027
      • Exhibit 34: Chart on Pharmaceutical and biotechnology companies - Market size and forecast 2022-2027 ($ million)
      • Exhibit 35: Data Table on Pharmaceutical and biotechnology companies - Market size and forecast 2022-2027 ($ million)
      • Exhibit 36: Chart on Pharmaceutical and biotechnology companies - Year-over-year growth 2022-2027 (%)
      • Exhibit 37: Data Table on Pharmaceutical and biotechnology companies - Year-over-year growth 2022-2027 (%)
    • 6.4 Cell banks - Market size and forecast 2022-2027
      • Exhibit 38: Chart on Cell banks - Market size and forecast 2022-2027 ($ million)
      • Exhibit 39: Data Table on Cell banks - Market size and forecast 2022-2027 ($ million)
      • Exhibit 40: Chart on Cell banks - Year-over-year growth 2022-2027 (%)
      • Exhibit 41: Data Table on Cell banks - Year-over-year growth 2022-2027 (%)
    • 6.5 Academic research institutes - Market size and forecast 2022-2027
      • Exhibit 42: Chart on Academic research institutes - Market size and forecast 2022-2027 ($ million)
      • Exhibit 43: Data Table on Academic research institutes - Market size and forecast 2022-2027 ($ million)
      • Exhibit 44: Chart on Academic research institutes - Year-over-year growth 2022-2027 (%)
      • Exhibit 45: Data Table on Academic research institutes - Year-over-year growth 2022-2027 (%)
    • 6.6 CROs - Market size and forecast 2022-2027
      • Exhibit 46: Chart on CROs - Market size and forecast 2022-2027 ($ million)
      • Exhibit 47: Data Table on CROs - Market size and forecast 2022-2027 ($ million)
      • Exhibit 48: Chart on CROs - Year-over-year growth 2022-2027 (%)
      • Exhibit 49: Data Table on CROs - Year-over-year growth 2022-2027 (%)
    • 6.7 Others - Market size and forecast 2022-2027
      • Exhibit 50: Chart on Others - Market size and forecast 2022-2027 ($ million)
      • Exhibit 51: Data Table on Others - Market size and forecast 2022-2027 ($ million)
      • Exhibit 52: Chart on Others - Year-over-year growth 2022-2027 (%)
      • Exhibit 53: Data Table on Others - Year-over-year growth 2022-2027 (%)
    • 6.8 Market opportunity by End-user
      • Exhibit 54: Market opportunity by End-user ($ million)
      • Exhibit 55: Data Table on Market opportunity by End-user ($ million)

    7 Market Segmentation by Product

    • 7.1 Market segments
      • Exhibit 56: Chart on Product - Market share 2022-2027 (%)
      • Exhibit 57: Data Table on Product - Market share 2022-2027 (%)
    • 7.2 Comparison by Product
      • Exhibit 58: Chart on Comparison by Product
      • Exhibit 59: Data Table on Comparison by Product
    • 7.3 Consumables - Market size and forecast 2022-2027
      • Exhibit 60: Chart on Consumables - Market size and forecast 2022-2027 ($ million)
      • Exhibit 61: Data Table on Consumables - Market size and forecast 2022-2027 ($ million)
      • Exhibit 62: Chart on Consumables - Year-over-year growth 2022-2027 (%)
      • Exhibit 63: Data Table on Consumables - Year-over-year growth 2022-2027 (%)
    • 7.4 Systems - Market size and forecast 2022-2027
      • Exhibit 64: Chart on Systems - Market size and forecast 2022-2027 ($ million)
      • Exhibit 65: Data Table on Systems - Market size and forecast 2022-2027 ($ million)
      • Exhibit 66: Chart on Systems - Year-over-year growth 2022-2027 (%)
      • Exhibit 67: Data Table on Systems - Year-over-year growth 2022-2027 (%)
    • 7.5 Market opportunity by Product
      • Exhibit 68: Market opportunity by Product ($ million)
      • Exhibit 69: Data Table on Market opportunity by Product ($ million)

    8 Customer Landscape

    • 8.1 Customer landscape overview
      • Exhibit 70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    9 Geographic Landscape

    • 9.1 Geographic segmentation
      • Exhibit 71: Chart on Market share by geography 2022-2027 (%)
      • Exhibit 72: Data Table on Market share by geography 2022-2027 (%)
    • 9.2 Geographic comparison
      • Exhibit 73: Chart on Geographic comparison
      • Exhibit 74: Data Table on Geographic comparison
    • 9.3 North America - Market size and forecast 2022-2027
      • Exhibit 75: Chart on North America - Market size and forecast 2022-2027 ($ million)
      • Exhibit 76: Data Table on North America - Market size and forecast 2022-2027 ($ million)
      • Exhibit 77: Chart on North America - Year-over-year growth 2022-2027 (%)
      • Exhibit 78: Data Table on North America - Year-over-year growth 2022-2027 (%)
    • 9.4 Europe - Market size and forecast 2022-2027
      • Exhibit 79: Chart on Europe - Market size and forecast 2022-2027 ($ million)
      • Exhibit 80: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
      • Exhibit 81: Chart on Europe - Year-over-year growth 2022-2027 (%)
      • Exhibit 82: Data Table on Europe - Year-over-year growth 2022-2027 (%)
    • 9.5 Asia - Market size and forecast 2022-2027
      • Exhibit 83: Chart on Asia - Market size and forecast 2022-2027 ($ million)
      • Exhibit 84: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
      • Exhibit 85: Chart on Asia - Year-over-year growth 2022-2027 (%)
      • Exhibit 86: Data Table on Asia - Year-over-year growth 2022-2027 (%)
    • 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
      • Exhibit 87: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
      • Exhibit 88: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
      • Exhibit 89: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
      • Exhibit 90: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
    • 9.7 US - Market size and forecast 2022-2027
      • Exhibit 91: Chart on US - Market size and forecast 2022-2027 ($ million)
      • Exhibit 92: Data Table on US - Market size and forecast 2022-2027 ($ million)
      • Exhibit 93: Chart on US - Year-over-year growth 2022-2027 (%)
      • Exhibit 94: Data Table on US - Year-over-year growth 2022-2027 (%)
    • 9.8 UK - Market size and forecast 2022-2027
      • Exhibit 95: Chart on UK - Market size and forecast 2022-2027 ($ million)
      • Exhibit 96: Data Table on UK - Market size and forecast 2022-2027 ($ million)
      • Exhibit 97: Chart on UK - Year-over-year growth 2022-2027 (%)
      • Exhibit 98: Data Table on UK - Year-over-year growth 2022-2027 (%)
    • 9.9 Canada - Market size and forecast 2022-2027
      • Exhibit 99: Chart on Canada - Market size and forecast 2022-2027 ($ million)
      • Exhibit 100: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
      • Exhibit 101: Chart on Canada - Year-over-year growth 2022-2027 (%)
      • Exhibit 102: Data Table on Canada - Year-over-year growth 2022-2027 (%)
    • 9.10 Germany - Market size and forecast 2022-2027
      • Exhibit 103: Chart on Germany - Market size and forecast 2022-2027 ($ million)
      • Exhibit 104: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
      • Exhibit 105: Chart on Germany - Year-over-year growth 2022-2027 (%)
      • Exhibit 106: Data Table on Germany - Year-over-year growth 2022-2027 (%)
    • 9.11 China - Market size and forecast 2022-2027
      • Exhibit 107: Chart on China - Market size and forecast 2022-2027 ($ million)
      • Exhibit 108: Data Table on China - Market size and forecast 2022-2027 ($ million)
      • Exhibit 109: Chart on China - Year-over-year growth 2022-2027 (%)
      • Exhibit 110: Data Table on China - Year-over-year growth 2022-2027 (%)
    • 9.12 Market opportunity by geography
      • Exhibit 111: Market opportunity by geography ($ million)
      • Exhibit 112: Data Tables on Market opportunity by geography ($ million)

    10 Drivers, Challenges, and Trends

    • 10.1 Market drivers
      • 10.2 Market challenges
        • 10.3 Impact of drivers and challenges
          • Exhibit 113: Impact of drivers and challenges in 2022 and 2027
        • 10.4 Market trends

          11 Vendor Landscape

          • 11.1 Overview
            • 11.2 Vendor landscape
              • Exhibit 114: Overview on Criticality of inputs and Factors of differentiation
            • 11.3 Landscape disruption
              • Exhibit 115: Overview on factors of disruption
            • 11.4 Industry risks
              • Exhibit 116: Impact of key risks on business

            12 Vendor Analysis

            • 12.1 Vendors covered
              • Exhibit 117: Vendors covered
            • 12.2 Market positioning of vendors
              • Exhibit 118: Matrix on vendor position and classification
            • 12.3 Agilent Technologies Inc.
              • Exhibit 119: Agilent Technologies Inc. - Overview
              • Exhibit 120: Agilent Technologies Inc. - Business segments
              • Exhibit 121: Agilent Technologies Inc. - Key offerings
              • Exhibit 122: Agilent Technologies Inc. - Segment focus
            • 12.4 ATCC
              • Exhibit 123: ATCC - Overview
              • Exhibit 124: ATCC - Product / Service
              • Exhibit 125: ATCC - Key offerings
            • 12.5 Akron Biotechnology LLC
              • Exhibit 126: Akron Biotechnology LLC - Overview
              • Exhibit 127: Akron Biotechnology LLC - Product / Service
              • Exhibit 128: Akron Biotechnology LLC - Key offerings
            • 12.6 Becton Dickinson and Co.
              • Exhibit 129: Becton Dickinson and Co. - Overview
              • Exhibit 130: Becton Dickinson and Co. - Business segments
              • Exhibit 131: Becton Dickinson and Co. - Key news
              • Exhibit 132: Becton Dickinson and Co. - Key offerings
              • Exhibit 133: Becton Dickinson and Co. - Segment focus
            • 12.7 Bio Techne Corp.
              • Exhibit 134: Bio Techne Corp. - Overview
              • Exhibit 135: Bio Techne Corp. - Business segments
              • Exhibit 136: Bio Techne Corp. - Key news
              • Exhibit 137: Bio Techne Corp. - Key offerings
              • Exhibit 138: Bio Techne Corp. - Segment focus
            • 12.8 Bionique Testing Laboratories Inc.
              • Exhibit 139: Bionique Testing Laboratories Inc. - Overview
              • Exhibit 140: Bionique Testing Laboratories Inc. - Product / Service
              • Exhibit 141: Bionique Testing Laboratories Inc. - Key offerings
            • 12.9 Charles River Laboratories International Inc.
              • Exhibit 142: Charles River Laboratories International Inc. - Overview
              • Exhibit 143: Charles River Laboratories International Inc. - Business segments
              • Exhibit 144: Charles River Laboratories International Inc. - Key news
              • Exhibit 145: Charles River Laboratories International Inc. - Key offerings
              • Exhibit 146: Charles River Laboratories International Inc. - Segment focus
            • 12.10 F. Hoffmann La Roche Ltd.
              • Exhibit 147: F. Hoffmann La Roche Ltd. - Overview
              • Exhibit 148: F. Hoffmann La Roche Ltd. - Business segments
              • Exhibit 149: F. Hoffmann La Roche Ltd. - Key news
              • Exhibit 150: F. Hoffmann La Roche Ltd. - Key offerings
              • Exhibit 151: F. Hoffmann La Roche Ltd. - Segment focus
            • 12.11 GeneCopoeia Inc.
              • Exhibit 152: GeneCopoeia Inc. - Overview
              • Exhibit 153: GeneCopoeia Inc. - Product / Service
              • Exhibit 154: GeneCopoeia Inc. - Key offerings
            • 12.12 InvivoGen Corp.
              • Exhibit 155: InvivoGen Corp. - Overview
              • Exhibit 156: InvivoGen Corp. - Product / Service
              • Exhibit 157: InvivoGen Corp. - Key offerings
            • 12.13 Lonza Group Ltd.
              • Exhibit 158: Lonza Group Ltd. - Overview
              • Exhibit 159: Lonza Group Ltd. - Business segments
              • Exhibit 160: Lonza Group Ltd. - Key news
              • Exhibit 161: Lonza Group Ltd. - Key offerings
              • Exhibit 162: Lonza Group Ltd. - Segment focus
            • 12.14 Merck KGaA
              • Exhibit 163: Merck KGaA - Overview
              • Exhibit 164: Merck KGaA - Business segments
              • Exhibit 165: Merck KGaA - Key news
              • Exhibit 166: Merck KGaA - Key offerings
              • Exhibit 167: Merck KGaA - Segment focus
            • 12.15 Norgen Biotek Corp.
              • Exhibit 168: Norgen Biotek Corp. - Overview
              • Exhibit 169: Norgen Biotek Corp. - Product / Service
              • Exhibit 170: Norgen Biotek Corp. - Key offerings
            • 12.16 Sartorius AG
              • Exhibit 171: Sartorius AG - Overview
              • Exhibit 172: Sartorius AG - Business segments
              • Exhibit 173: Sartorius AG - Key news
              • Exhibit 174: Sartorius AG - Key offerings
              • Exhibit 175: Sartorius AG - Segment focus
            • 12.17 Thermo Fisher Scientific Inc.
              • Exhibit 176: Thermo Fisher Scientific Inc. - Overview
              • Exhibit 177: Thermo Fisher Scientific Inc. - Business segments
              • Exhibit 178: Thermo Fisher Scientific Inc. - Key news
              • Exhibit 179: Thermo Fisher Scientific Inc. - Key offerings
              • Exhibit 180: Thermo Fisher Scientific Inc. - Segment focus

            13 Appendix

            • 13.1 Scope of the report
              • 13.2 Inclusions and exclusions checklist
                • Exhibit 181: Inclusions checklist
                • Exhibit 182: Exclusions checklist
              • 13.3 Currency conversion rates for US$
                • Exhibit 183: Currency conversion rates for US$
              • 13.4 Research methodology
                • Exhibit 184: Research methodology
                • Exhibit 185: Validation techniques employed for market sizing
                • Exhibit 186: Information sources
              • 13.5 List of abbreviations
                • Exhibit 187: List of abbreviations

              Research Framework

              Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

              INFORMATION SOURCES

              Primary sources

              • Manufacturers and suppliers
              • Channel partners
              • Industry experts
              • Strategic decision makers

              Secondary sources

              • Industry journals and periodicals
              • Government data
              • Financial reports of key industry players
              • Historical data
              • Press releases

              DATA ANALYSIS

              Data Synthesis

              • Collation of data
              • Estimation of key figures
              • Analysis of derived insights

              Data Validation

              • Triangulation with data models
              • Reference against proprietary databases
              • Corroboration with industry experts

              REPORT WRITING

              Qualitative

              • Market drivers
              • Market challenges
              • Market trends
              • Five forces analysis

              Quantitative

              • Market size and forecast
              • Market segmentation
              • Geographical insights
              • Competitive landscape

              PURCHASE FULL REPORT OF

              mycoplasma testing market

              QUICK BUY

              Key Questions Answered

              • What are the key global market and the regional market share?
              • What are the revenue-generating key market segments?
              • What are the key factors driving and challenging this market’s growth?
              • Who are the key market vendors and their growth strategies?
              • What are the latest trends influencing the growth of this market?
              • What are the variables influencing the market growth in the primary regions?
              • What are the factors influencing the growth of the parent market?

              Why should you prefer Technavio's market insights report?

              • Off-the-shelf research reports
              • Reports can be tailored to meet the customer's needs
              • Trusted by more than 100 fortune 500 organizations
              • Information about the market's key drivers, trends, and challenges
              • Parent market analysis
              • Every week, 50,000 people visit our subscription platform
              • Detailed vendors report with competitive landscape
              • Covid-19 impact and recovery analysis
              • Data on revenue-generating market segments
              • Details on the market shares of various regions
              • Five-force market analysis